Pelthos to Merge With Castle Creek in Share-and-Milestone Deal
Pelthos agreed to acquire Castle Creek Biosciences in a two-step merger, issuing 5.2 million shares at closing and potentially paying up to $300 million in milestones. The transaction is paired with a PIPE financing.